ALLISON TOBAR: Open Payments
NPI 1780143586 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 16 payments from 11 companies in 2025. Trend: 2023 $76 · 2024 $1,182 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $36 |
| BridgeBio Pharma, Inc. | 1 | $28 |
| HEARTFLOW, INC. | 1 | $27 |
| CVRx, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
Products named: LEQVIO, CAMZYOS, WAINUA, LifeVest, WINREVAIR, Attruby, FFRct, Barostim Neo System.
Industry payments across CA — which companies pay providers there.
